Ventricular arrhythmias in heart failure: to treat or not to treat?
The medical management of patients with CHF and ventricular arrhythmias is one of the most challenging clinical situations frequently encountered by physicians on a daily basis. Reviewed and examined in this article are available data regarding the clinical relevance and prevalence of ventricular arrhythmias, their prognostic importance in patients with CHF, and the role of available therapeutic modalities and their limitations in the management of these patients.
Deedwania
P C
PC
Department of Medicine, University of California, San Francisco School of Medicine.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D016757:Death, Sudden, Cardiac / Q000209:etiology; D006333:Heart Failure / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D017180:Tachycardia, Ventricular / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D014665:Vasodilator Agents